Tricaprilin Liquid Formulation PK Study

Summary

The purpose of this study is to evaluate the pharmacokinetics, safety, and tolerability of new liquid formulations of tricaprilin, with the aim of finding a suitable formulation to advance in development. This is a three-part, part-randomised study that include single-dose, food effect, and titration tolerability in up to 80 healthy participants.

Timeline

Start

2021-08-31

Primary completion

2022-03-18

Completion

2022-07-19

Outcome

Outcome not reported

Stopped (Enrollment): “Part 1 was completed, Part 2 and Part 3 of the study were not conducted under this study protocol due to subject recruitment difficulty.”

Drugs

Indications